312 related articles for article (PubMed ID: 8423070)
21. Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma.
Ennis DP; Cassidy JP; Mahon BP
Clin Exp Allergy; 2004 Sep; 34(9):1488-97. PubMed ID: 15347385
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of efficacy in terms of antibody levels and cell-mediated immunity of acellular pertussis vaccines in a murine model of respiratory infection.
Watanabe M; Komatsu E; Sato T; Nagai M
FEMS Immunol Med Microbiol; 2002 Jul; 33(3):219-25. PubMed ID: 12110485
[TBL] [Abstract][Full Text] [Related]
23. The immunoregulatory role of CD4⁺ FoxP3⁺ CD25⁻ regulatory T cells in lungs of mice infected with Bordetella pertussis.
Coleman MM; Finlay CM; Moran B; Keane J; Dunne PJ; Mills KH
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):413-24. PubMed ID: 22211712
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells.
Mahon BP; Ryan MS; Griffin F; Mills KH
Infect Immun; 1996 Dec; 64(12):5295-301. PubMed ID: 8945580
[TBL] [Abstract][Full Text] [Related]
25. Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis.
Petersen JW; Ibsen PH; Hasløv K; Heron I
Infect Immun; 1992 Nov; 60(11):4563-70. PubMed ID: 1398968
[TBL] [Abstract][Full Text] [Related]
26. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis.
McGuirk P; McCann C; Mills KH
J Exp Med; 2002 Jan; 195(2):221-31. PubMed ID: 11805149
[TBL] [Abstract][Full Text] [Related]
27. High dose interleukin-12 exacerbates Bordetella pertussis infection and is associated with suppression of cell-mediated immunity in a murine aerosol challenge model.
Carter CR; Dagg BM; Whitmore KM; Keeble JR; Asokanathan C; Xing D; Walker KB
Clin Exp Immunol; 2004 Feb; 135(2):233-9. PubMed ID: 14738450
[TBL] [Abstract][Full Text] [Related]
28. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
[TBL] [Abstract][Full Text] [Related]
29. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
[TBL] [Abstract][Full Text] [Related]
30. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
[TBL] [Abstract][Full Text] [Related]
31. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
Cahill ES; O'Hagan DT; Illum L; Barnard A; Mills KH; Redhead K
Vaccine; 1995 Apr; 13(5):455-62. PubMed ID: 7639014
[TBL] [Abstract][Full Text] [Related]
32. Treatment of mice with IL-12 DNA constructs leads to augmented NK activity in lungs but low IFN-gamma release -- implications for Bordetella pertussis infections following aerosol challenge.
Carter CR; Dagg BM; Whitmore KM; Keeble JR; Asokanathan C; Rodgers A; Watanabe M; Xing D; Walker KB
Cytokine; 2005 May; 30(3):100-8. PubMed ID: 15826816
[TBL] [Abstract][Full Text] [Related]
33. The cellular immune response to Bordetella pertussis in two children with whooping cough.
Hafler JP; Pohl-Koppe A
Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
[TBL] [Abstract][Full Text] [Related]
34. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.
Cornford-Nairns R; Daggard G; Mukkur T
J Microbiol Biotechnol; 2012 Jun; 22(6):856-65. PubMed ID: 22573165
[TBL] [Abstract][Full Text] [Related]
35. Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection.
Fry SR; Chen AY; Daggard G; Mukkur TKS
J Med Microbiol; 2008 Jan; 57(Pt 1):28-35. PubMed ID: 18065664
[TBL] [Abstract][Full Text] [Related]
36. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
Cahill ES; O'Hagan DT; Illum L; Redhead K
FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
[TBL] [Abstract][Full Text] [Related]
37. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
[TBL] [Abstract][Full Text] [Related]
38. Long-lived respiratory immune response to filamentous hemagglutinin following Bordetella pertussis infection.
Amsbaugh DF; Li ZM; Shahin RD
Infect Immun; 1993 Apr; 61(4):1447-52. PubMed ID: 8454349
[TBL] [Abstract][Full Text] [Related]
39. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
[TBL] [Abstract][Full Text] [Related]
40. Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets.
Elahi S; Thompson DR; Van Kessel J; Babiuk LA; Gerdts V
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28167667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
